News

Novo Nordisk river nu en aftale i stykker, som ellers blev underskrevet for mindre end to måneder siden. Sidst i april indgik ...
Det oplyser Novo i en meddelelse, efter at selskabet i starten af ugen droppede et andet partnerskab med Hims & Hers, skriver MarketWire. Aftalen med teleudbyderen af medicin Hims & Hers var mindre ...
Regeringen er efter måneders hårde forhandlinger blevet enig med arbejdsmarkedets parter om en aftale, der skal skaffe mere ...
Emil Jørgensen, der er Jimmi Lillelunds nevø, blev i 2021 idømt tre års fængsel i en narkosag. De tre år er afsonet og på ...
Ved hjælp af blandt andet kvartalsvise lønreguleringer har Novo Nordisk sikret ligeløn. Faktisk tjener kvinderne i Novo Nordisk mere end mændene, skriver Finans. Ifølge en analyse tjener kvinderne tre ...
Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the drugmaker in a more vulnerable position when rival Eli Lilly ...
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
Shares in Denmark's pharmaceutical giant Novo Nordisk ( NVO 0.63%) were lower by 4% as of 11 a.m. ET today. The move comes as ...
This morning, the Danish pharmaceutical giant Novo Nordisk announced the abrupt end of its brief partnership with telehealth ...
Drugmaker Novo Nordisk said it is halting its agreement with telehealth company Hims & Hers after less than two months, ...
Positive news from the laboratory was the wind beneath the wings of Novo Nordisk (NYSE: NVO) stock on Thursday. The Denmark-based pharmaceutical company, famed for its Ozempic and Wegovy drugs, saw ...
Much like the long-term users of its most popular product, Novo Nordisk's (NYSE: NVO) stock has slimmed down considerably of late. Share prices of the company, which developed and sells weight ...